Trulieve Cannabis Corp. — Q2 2021 Form 10-Q
Reporting period: Quarter and six months ended June 30, 2021. Trulieve is a U.S. multi-state cannabis operator licensed in six states. Substantially all revenue was generated from medical cannabis sales in Florida; other states and adult-use operations were not yet material. Figures below are in U.S. dollars unless stated otherwise.
Financial performance
| Metric | Q2 2021 | Q2 2020 | Six months 2021 | Six months 2020 |
|---|---|---|---|---|
| Revenue | $215.1m | $120.8m | $408.9m | $216.8m |
| Gross profit / margin | $144.5m / 67% | $90.5m / 75% | $279.7m / 68% | $164.4m / 76% |
| Operating income | $76.3m | $52.5m | $148.9m | $95.0m |
| Net income | $40.9m | $18.9m | $71.0m | $42.5m |
| Diluted EPS | $0.31 | $0.16 | $0.55 | $0.37 |
| Adjusted EBITDA (non-GAAP) | $94.9m | $61.4m | $185.7m | $109.9m |
Q2 revenue increased 78% year over year, attributed to organic retail growth, more products and patients, and 40 dispensaries opened or acquired since June 2020. Net income rose 116%. However, gross margin fell to 67% from 75%; management cited new-market expansion, inventory flow-through, product mix, and pricing and labor factors. For the six-month period, operating cash flow was $49.2m, down from $77.7m, while capital investment and acquisitions drove investing cash outflow of $136.7m. Financing provided $230.0m, principally from the public share offering.
Balance sheet and liquidity
- Cash and cash equivalents were $289.2m at June 30, 2021, versus $146.7m at year-end 2020. Current assets were $442.1m and current liabilities $76.7m.
- Total assets were $1.146bn; total liabilities were $390.1m; shareholders’ equity was $756.2m.
- Debt included $130m face value of private placement notes due June 2024, $18m of other notes (including $12m related-party notes), and $44.4m of finance lease liabilities. Construction finance liability was $90.3m. Operating lease liabilities were $33.0m.
- Management stated existing cash was expected to meet anticipated cash needs for at least 12 months from the report’s issuance date. The company may seek additional debt or equity for longer-term needs; availability and terms are not assured.
Changes, outlook and notable items
- Capital spending on property and equipment was $115.3m in the first half, versus $27.9m a year earlier, supporting facility and dispensary expansion. Inventories increased to $112.6m from $98.3m at year-end.
- The April 2021 public offering generated $217.9m net proceeds and issued 5.75m subordinate voting shares. Total issued common shares were 127.0m at June 30, versus 119.6m at December 31, 2020.
- Acquisitions during the quarter included West Virginia permits and a Massachusetts adult-use dispensary license; these were accounted for as asset acquisitions. After quarter-end, Trulieve acquired Massachusetts assets and Keystone Shops in Pennsylvania for stated consideration of $4.8m and $60m, respectively. Keystone Shops consideration included $20m cash and $40m in shares, plus up to $5m contingent on Pennsylvania adult-use legalization.
- Trulieve agreed to acquire Harvest Health & Recreation in a share transaction valued at approximately $2.1bn based on the May 7 share price. The deal remained subject to shareholder, court, regulatory and other closing conditions. The agreement provides reciprocal $100m termination fees in specified circumstances and potential loans to Harvest if closing is delayed beyond specified dates.
- No numeric revenue, profit or EBITDA guidance was provided. Management expected sales and marketing, general and administrative, and expansion-related costs to rise as the company grows; it also anticipated continued acquisition, integration, compliance and infrastructure spending.
- Income tax expense was $63.7m for the first half, with a 47% effective tax rate. Management noted IRC Section 280E restricts cannabis businesses’ deductible expenses to those directly related to production.
Risks and contingencies
- Cannabis remains illegal under U.S. federal law, creating potential enforcement and asset-forfeiture risks despite state licensing. All revenue and long-lived assets were in the United States.
- A consolidated securities class action alleges misleading statements about prior financial statements and the company’s business. Trulieve said it considers the suit immaterial and without merit and intends to defend it.
- Related-party exposures include $12m of notes payable and construction services provided by a company partly owned by the CEO’s spouse. The filing reports board review and legal-office review of supplier invoices.
- Management reported disclosure controls were effective and no material change in internal control over financial reporting during the quarter. No material risk-factor changes from the 2020 Form 10-K were reported.
Important facts for investors to verify
- Whether gross-margin compression persists and how new-market growth, product mix, pricing, labor and inventory flow-through affect profitability.
- How much of operating cash generation is absorbed by capital spending, inventory and acquisitions, and whether cash remains adequate for expansion and the Harvest transaction.
- Harvest transaction closing conditions, final consideration adjustments, potential termination fees and any interim loans.
- Final purchase accounting and performance of recent acquisitions, including Keystone Shops and Massachusetts assets.
- Federal cannabis-law and Section 280E exposure, the securities litigation outcome, and related-party construction and financing arrangements.
- Adjusted EBITDA is a non-GAAP measure; compare it with GAAP net income and review the filing’s reconciliation and excluded costs.